OncoScan
This test evaluates the expression of over 40 oncogenes and cancer-suppressing genes related to responses to conventional chemotherapy and targeted therapies. It helps identify specific tumor subtypes for personalized treatment.
- The description claims that this test can identify specific tumor subtypes and improve treatment effectiveness.
Variants (1)
- Default Title — 3320.75 BRL — In stock
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
65%